180 related articles for article (PubMed ID: 32170481)
1. Synchronous and Metachronous Peritoneal Metastases in Patients with Left-Sided Obstructive Colon Cancer.
Veld JV; Wisselink DD; Amelung FJ; Consten ECJ; de Wilt JHW; de Hingh I; Bemelman WA; van Hooft JE; Tanis PJ;
Ann Surg Oncol; 2020 Aug; 27(8):2762-2773. PubMed ID: 32170481
[TBL] [Abstract][Full Text] [Related]
2. Increase in the incidence of synchronous and metachronous peritoneal metastases in patients with colorectal cancer: A nationwide study.
Lurvink RJ; Bakkers C; Rijken A; van Erning FN; Nienhuijs SW; Burger JW; Creemers GJ; Verhoef C; Lemmens VE; De Hingh IH
Eur J Surg Oncol; 2021 May; 47(5):1026-1033. PubMed ID: 33272737
[TBL] [Abstract][Full Text] [Related]
3. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
[TBL] [Abstract][Full Text] [Related]
5. Metachronous peritoneal metastases following curative resection for colon cancer: Understanding risk factors and patterns of recurrence.
Le VH; Thornblade L; Ituarte PHG; Lai LL; Melstrom KA
J Surg Oncol; 2021 Feb; 123(2):622-629. PubMed ID: 33616972
[TBL] [Abstract][Full Text] [Related]
6. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer.
Segelman J; Granath F; Holm T; Machado M; Mahteme H; Martling A
Br J Surg; 2012 May; 99(5):699-705. PubMed ID: 22287157
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for appendiceal and colorectal peritoneal metastases.
Enblad M; Graf W; Birgisson H
Eur J Surg Oncol; 2018 Jul; 44(7):997-1005. PubMed ID: 29576463
[TBL] [Abstract][Full Text] [Related]
8. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
[TBL] [Abstract][Full Text] [Related]
9. Higher incidence of metachronous advanced neoplasia in patients with synchronous advanced neoplasia and left-sided colorectal resection for colorectal cancer.
Yabuuchi Y; Imai K; Hotta K; Ito S; Kishida Y; Yamaguchi T; Shiomi A; Kinugasa Y; Yoshida M; Tanaka M; Kawata N; Kakushima N; Takizawa K; Ishiwatari H; Matsubayashi H; Ono H
Gastrointest Endosc; 2018 Aug; 88(2):348-359.e1. PubMed ID: 29574125
[TBL] [Abstract][Full Text] [Related]
10. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and prognosis of synchronous and metachronous colon cancer metastases: a French population-based study.
Ghiringhelli F; Hennequin A; Drouillard A; Lepage C; Faivre J; Bouvier AM
Dig Liver Dis; 2014 Sep; 46(9):854-8. PubMed ID: 24908575
[TBL] [Abstract][Full Text] [Related]
12. Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
Kunitomo A; Ouchi A; Komori K; Kinoshita T; Sato Y; Abe T; Ito S; Sano T; Shimizu Y
Ann Surg Oncol; 2023 Dec; 30(13):8501-8508. PubMed ID: 37658266
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of metachronous colorectal neoplasm after curative resection of colorectal cancer in Korean patients.
Lee SY; Kim BC; Han KS; Hong CW; Sohn DK; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Jul; 15(7):367-76. PubMed ID: 24773758
[TBL] [Abstract][Full Text] [Related]
14. Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer.
Nagata H; Ishihara S; Hata K; Murono K; Kaneko M; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Nozawa H; Watanabe T
Ann Surg Oncol; 2017 May; 24(5):1269-1280. PubMed ID: 27995451
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, oncologic results and risk stratification model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long-term follow-up study.
Cerdán-Santacruz C; Cano-Valderrama Ó; Peña Ros E; Serrano Del Moral Á; Pereira Pérez F; Flor Lorente B; Biondo S;
Tech Coloproctol; 2023 Nov; 27(11):1025-1036. PubMed ID: 37248370
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
[TBL] [Abstract][Full Text] [Related]
17. The impact of an open or laparoscopic approach on the development of metachronous peritoneal metastases after primary resection of colorectal cancer: results from a population-based cohort study.
Lurvink RJ; Rijken A; Bakkers C; Lemmens VE; de Reuver PR; Tuynman JB; Kok NF; Nienhuijs SW; van Erning FN; de Hingh IHJT
Surg Endosc; 2022 Sep; 36(9):6551-6557. PubMed ID: 35059835
[TBL] [Abstract][Full Text] [Related]
18. Impact of absence of consensual cutoff time distinguishing between synchronous and metachronous metastases: illustration with colorectal cancer.
Willem H; Jooste V; Boussari O; Romain G; Bouvier AM
Eur J Cancer Prev; 2019 May; 28(3):167-172. PubMed ID: 29738323
[TBL] [Abstract][Full Text] [Related]
19. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study.
Bhatt A; Bhamre R; Rohila J; Kalikar V; Desouza A; Saklani A
Colorectal Dis; 2019 Mar; 21(3):287-296. PubMed ID: 30457185
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.
Patel A; Williams N; Parsons N; Ali O; Peters F; Ranat R; Shah J; Spector E; Arasaradnam RP
Int J Colorectal Dis; 2017 Nov; 32(11):1609-1616. PubMed ID: 28828520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
